Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

A 12-Year Experience of Hidradenitis Suppurativa Management

Vankevicčiūtė, Rasa Aurelija, MD; Polozovaitė, Brigita, MD; Trapikas, Julius, MD; Raudonis, Tadas, MD; Grigaitienė, Jūratė, MD, PhP; Bylaitė-Bucčinskienė, Matilda, MD, PhD

Advances in Skin & Wound Care: January 2019 - Volume 32 - Issue 1 - p 1–7
doi: 10.1097/01.ASW.0000549611.06727.52
ONLINE EXCLUSIVE

BACKGROUND: Although treatment recommendations for hidradenitis suppurativa (HS) are well known, practical experience implementing them in Lithuania has not been reported yet.

OBJECTIVE: To review clinical findings and treatment options used in patients with HS in the largest center of dermatology and venereology in Lithuania from 2005 to 2016.

METHODS: A retrospective single-center medical file analysis was conducted on 46 patients with HS. Demographic information, patient history, and treatment results were included in the final analysis. χ2 Tests were used. Statistical significance was set at P ≤ .05.

MAIN RESULTS: Of the 46 patients, 52.2% were male. Percentages of patients with Hurley stages I, II, and III were 41.3%, 30.4%, and 28.3%, respectively. Patients with Hurley III HS were more likely to be smokers and obese. The most commonly prescribed medications were systemic antibiotics (76.1%) and systemic retinoids (37.0%). Systemic corticosteroids (19.6%) were more often prescribed to patients with Hurley III. Surgical procedures were performed in 54.3% of patients. The most common complication of the disease was contracture (13.0%).

CONCLUSIONS: This study revealed an association between smoking and obesity and the most severe stage of HS. Results showed that traditional medications used in this study were not effective for severe HS.

In the Faculty of Medicine, Vilnius University, Vilnius, Lithuania, Rasa Aurelija Vankevicčiūtė, MD, is a dermatology resident; Brigita Polozovaitė, MD, is a graduate; Julius Trapikas, MD, is a graduate; Tadas Raudonis, MD, is a dermatology resident and faculty; Jūratė Grigaitienė, MD, PhP, is Department Head; and Matilda Bylaitė-Bucčinskienė, MD, PhD, is Professor of Dermatology. Acknowledgments: The authors thank the personnel of the Centre of Dermatovenereology of Vilnius University Hospital Santaros Klinikos for their help with medical file analysis. The authors have disclosed no financial relationships related to this article. Submitted July 6, 2018; accepted in revised form August 28, 2018.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.